Literature DB >> 19863310

Acute tympanic membrane perforations and the early immunological response in rats.

Jamel Tahar Aissa1, Malou Hultcrantz.   

Abstract

CONCLUSIONS: This study showed that macrophages, B cells, and T cells occurred at different frequencies, localizations, and times after acute laser tympanic membrane perforation. Immunological cells were most prevalent in the proliferative mass adjacent to the annulus region. The cellular immunological response in freshly perforated eardrums was unexpectedly aggressive.
OBJECTIVES: To study the occurrence of immunocompetent cells during the healing process of fresh perforated tympanic membranes. The information could be used to develop alternative outpatient procedures in the cure of chronic perforations, replacing conventional surgery.
MATERIALS AND METHODS: A laser myringotomy was carried out in Sprague-Dawley rats, which were sacrificed at 3 and 6 days after the myringotomy. Tympanic membrane sections were stained immunohistochemically according to the avidin-biotin method, targeting macrophages, B cells, and T cells. Semi-quantification was performed; positive cells were counted and mean values were calculated.
RESULTS: Macrophages and B cells were most frequent at day 6 and T cells at day 3 after laser myringotomy. B cells were the most prevalent studied cell type. T cells peaked at day 3, after which they decreased in number. Most immunocompetent cells were observed in the proliferative mass at the edge of the perforation.

Entities:  

Mesh:

Year:  2009        PMID: 19863310     DOI: 10.3109/00016480802669552

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  1 in total

1.  High prevalence of hearing impairment in HIV-infected Peruvian children.

Authors:  Christina K Chao; Josephine A Czechowicz; Anna H Messner; Jorge Alarcón; Lenka Kolevic Roca; Marsi M Larragán Rodriguez; César Gutiérrez Villafuerte; Silvia M Montano; Joseph R Zunt
Journal:  Otolaryngol Head Neck Surg       Date:  2011-11-29       Impact factor: 3.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.